STRN相关文献与解析，生知库 | 链接生命科学的每一步

Erratum: MicroRNA Profile Identifies miR-6165 Could Suppress Gastric Cancer Migration and Invasion by Targeting STRN4 [Corrigendum]

勘误：MicroRNA谱分析表明miR-6165可通过靶向STRN4抑制胃癌的迁移和侵袭[更正]

期刊:Oncotargets and Therapy

影响因子:2.8

doi:10.2147/OTT.S608224

Elevated KNSTRN as a potential indicator for triple-negative breast cancer progression and immune infiltration

KNSTRN 水平升高可能是三阴性乳腺癌进展和免疫浸润的潜在指标

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1572359

Song, Yurong; Liu, Yuxi; Liu, Xiao; Qi, Minfang; Sun, Zhidong; Cao, Yuan

Pharmacological Targeting of DHHC9-Mediated STRN4 Palmitoylation to Suppress YAP-Driven Cancer Metastasis

通过药物靶向DHHC9介导的STRN4棕榈酰化来抑制YAP驱动的癌症转移

期刊:Journal of Cellular and Molecular Medicine

影响因子:4.3

doi:10.1111/jcmm.70815

Yang Tian,Wei Li,Qing Zhai,Ying Yu,Jiaxin Yuan,Yan Ma,Jingjing Yang,Mingyue Li,Wenwen Chang,Wenjing Li,Keke Huang,Chongran Sun,Chen Zeng,Yingdi Sun,Jiabao Gu,Huilin Zhang,Dameng Li,Yanan Yu,Lu Hu,Peng Zhang,Bo Ma,Junnian Zheng,Pan Li,Feng Guo,Yang Sun

The circRNA circKNSTRN promotes breast cancer progression by modulating the miR-320a-3p/SPAG5 axis.

环状RNA circKNSTRN通过调节miR-320a-3p/SPAG5轴促进乳腺癌进展。

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-29343-1

Zhou Xiaoli, He Yiting, Sun Yangyang, Li Yubing, Cheng Yuqing, Tang Liming

Action inflexibility and compulsive-like behavior accompany neurobiological alterations in the anterior orbitofrontal cortex and associated striatal nuclei

动作不灵活和强迫行为伴随前眶额皮质和相关纹状体核的神经生物学改变

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-024-84369-1

Laura M Butkovich, Sophie T Yount, Aylet T Allen, Esther H Seo, Andrew M Swanson, Shannon L Gourley

FBStrNet: Automatic Fetal Brain Structure Detection in Early Pregnancy Ultrasound Images.

FBStrNet：早期妊娠超声图像中胎儿脑部结构的自动检测。

期刊:Sensors

影响因子:3.5

doi:10.3390/s25165034

STRN

发表日期：2025

文献求助收藏

Successful Treatment of Osimertinib Resistance in an EGFR-Mutant Lung Cancer Patient With a Rare STRN3-ALK Fusion Using Brigatinib and Osimertinib

使用布加替尼和奥希替尼成功治疗了一例携带罕见STRN3-ALK融合基因的EGFR突变肺癌患者的奥希替尼耐药性

期刊:Kaohsiung Journal of Medical Sciences

影响因子:3.1

doi:10.1002/kjm2.70021

Kuo, Chia-Yu; Lai, Wei-An; Lee, Tai-Huang; Yang, Chih-Jen

Alectinib efficacy in advanced lung adenocarcinoma with coexistence of a novel ALK-MTUS2 and STRN3-ALK double fusion: A case report and literature review

阿来替尼治疗伴有新型ALK-MTUS2和STRN3-ALK双融合基因的晚期肺腺癌的疗效：病例报告及文献综述

期刊:Oncology Letters

影响因子:2.2

doi:10.3892/ol.2025.15178

Qiu, Xirui; Wei, Yu; Wang, Xiaoxiao; Xu, Siyan; Zhang, Yaru; He, Hailang; Zhou, Xianmei

Sustained response to larotrectinib in a pediatric patient with recurrent STRN3::NTRK2 fusion-positive pilocytic astrocytoma

一名患有复发性STRN3::NTRK2融合阳性毛细胞星形细胞瘤的儿科患者对拉罗替尼治疗有持续反应

期刊:CNS oncology

影响因子:

doi:10.1080/20450907.2025.2558455

Balasubramanian, Kishore; Fung, Kar-Ming; McNall-Knapp, Rene Y; Balsara, Karl

KNSTRN knockdown impairs autophagy flux to inhibit bladder cancer progression.

KNSTRN 敲低会损害自噬通量，从而抑制膀胱癌的进展。

Erratum: MicroRNA Profile Identifies miR-6165 Could Suppress Gastric Cancer Migration and Invasion by Targeting STRN4 [Corrigendum]

勘误：MicroRNA谱分析表明miR-6165可通过靶向STRN4抑制胃癌的迁移和侵袭[更正]

Elevated KNSTRN as a potential indicator for triple-negative breast cancer progression and immune infiltration

KNSTRN 水平升高可能是三阴性乳腺癌进展和免疫浸润的潜在指标

Pharmacological Targeting of DHHC9-Mediated STRN4 Palmitoylation to Suppress YAP-Driven Cancer Metastasis

通过药物靶向DHHC9介导的STRN4棕榈酰化来抑制YAP驱动的癌症转移

The circRNA circKNSTRN promotes breast cancer progression by modulating the miR-320a-3p/SPAG5 axis.

环状RNA circKNSTRN通过调节miR-320a-3p/SPAG5轴促进乳腺癌进展。

Action inflexibility and compulsive-like behavior accompany neurobiological alterations in the anterior orbitofrontal cortex and associated striatal nuclei

动作不灵活和强迫行为伴随前眶额皮质和相关纹状体核的神经生物学改变

FBStrNet: Automatic Fetal Brain Structure Detection in Early Pregnancy Ultrasound Images.

FBStrNet：早期妊娠超声图像中胎儿脑部结构的自动检测。

Successful Treatment of Osimertinib Resistance in an EGFR-Mutant Lung Cancer Patient With a Rare STRN3-ALK Fusion Using Brigatinib and Osimertinib

使用布加替尼和奥希替尼成功治疗了一例携带罕见STRN3-ALK融合基因的EGFR突变肺癌患者的奥希替尼耐药性

Alectinib efficacy in advanced lung adenocarcinoma with coexistence of a novel ALK-MTUS2 and STRN3-ALK double fusion: A case report and literature review

阿来替尼治疗伴有新型ALK-MTUS2和STRN3-ALK双融合基因的晚期肺腺癌的疗效：病例报告及文献综述

Sustained response to larotrectinib in a pediatric patient with recurrent STRN3::NTRK2 fusion-positive pilocytic astrocytoma

一名患有复发性STRN3::NTRK2融合阳性毛细胞星形细胞瘤的儿科患者对拉罗替尼治疗有持续反应